Overview

• Current NHS plans aim to provide Mounjaro to 220,000 high-priority patients over three years, with full coverage for 3.4 million eligible individuals projected to take 12 years.
• The Tony Blair Institute proposes expanding eligibility to those with a BMI over 27 and enabling postal delivery via the NHS app, estimating £52 billion in economic savings by 2050.
• Approximately 1.5 million people accessed weight-loss jabs privately last month, underscoring inequities in the two-tier system of access.
• Clinical data shows Mounjaro's effectiveness in reducing obesity-related conditions, though side effects include gastrointestinal issues and rare cases of pancreatitis.
• Patient experiences, such as Angela Brown’s dramatic weight loss and subsequent struggles with excess skin, highlight both the potential and challenges of these treatments.